What does PHARMACIE DU CHANT DES OISEAUX do?

PHARMACIE DU CHANT DES OISEAUX is a pharmacy in Châtelet. Private Limited, started on 2 October 2000, 1 establishment.

What is the address of PHARMACIE DU CHANT DES OISEAUX?

The registered office of PHARMACIE DU CHANT DES OISEAUX is located at Rue de Gilly 273, 6200 Châtelet.

Is PHARMACIE DU CHANT DES OISEAUX still active?

Yes. According to the CBE (20 September 2026) PHARMACIE DU CHANT DES OISEAUX is active, legal situation “Normale toestand”, started on 2 October 2000.

Is PHARMACIE DU CHANT DES OISEAUX registered on Peppol?

Yes, PHARMACIE DU CHANT DES OISEAUX is registered on the Peppol network with ID 0208:0472886975.

What is the enterprise number of PHARMACIE DU CHANT DES OISEAUX?

The enterprise number of PHARMACIE DU CHANT DES OISEAUX is BE0472886975.

When was PHARMACIE DU CHANT DES OISEAUX founded?

PHARMACIE DU CHANT DES OISEAUX was founded on 2 October 2000.

Who are the directors of PHARMACIE DU CHANT DES OISEAUX?

According to the 2025 annual accounts, the directors of PHARMACIE DU CHANT DES OISEAUX are: Isabelle GIBON.

Is PHARMACIE DU CHANT DES OISEAUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 October 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DU CHANT DES OISEAUX make in 2025?

PHARMACIE DU CHANT DES OISEAUX posted a profit after taxes of € 19,983 in financial year 2025.

What is the revenue of PHARMACIE DU CHANT DES OISEAUX?

As a small company, PHARMACIE DU CHANT DES OISEAUX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 99,436.

PHARMACIE DU CHANT DES OISEAUX (Private Limited)

Dossier PHARMACIE DU CHANT DES OISEAUX, printed on 20 September 2026 from databakkes.be/en/0472886975/pharmacie-du-chant-des-oiseaux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DU CHANT DES OISEAUX from Châtelet, company number BE0472886975, closed financial year 2025 with a result of € 19,983 after tax. For that financial year PHARMACIE DU CHANT DES OISEAUX recorded a gross margin of € 99,436 and equity of € 187,210. Compared with financial year 2024, the result moved from € 23,878 to € 19,983. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 187,210

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 19,983

▼ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 119,866

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 10,900 paid out

55 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 52,173

▼ 26% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,727

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 7,992

▼ 56% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 88,427

▲ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 20,442

▲ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 98,637 Gross margin 2022: € 98,637 First fiscal year in the series	€ 139,552 Gross margin 2023: € 139,552 ▲ 41% vs 2022 (€ 98,637) Favourable step	€ 123,013 Gross margin 2024: € 123,013 ▼ 12% vs 2023 (€ 139,552) Unfavourable step	€ 99,436 Gross margin 2025: € 99,436 ▼ 19% vs 2024 (€ 123,013) Unfavourable step	▼ 19%
Profit after taxes	€ 9,757 Profit after taxes 2022: € 9,757 First fiscal year in the series	€ 48,248 Profit after taxes 2023: € 48,248 ▲ € 38,491 vs 2022 (€ 9,757) Favourable step	€ 23,878 Profit after taxes 2024: € 23,878 ▼ 51% vs 2023 (€ 48,248) Unfavourable step	€ 19,983 Profit after taxes 2025: € 19,983 ▼ 16% vs 2024 (€ 23,878) Unfavourable step	▼ 16%
Equity	€ 121,701 Equity 2022: € 121,701 First fiscal year in the series	€ 162,349 Equity 2023: € 162,349 ▲ 33% vs 2022 (€ 121,701) Favourable step	€ 178,127 Equity 2024: € 178,127 ▲ 10% vs 2023 (€ 162,349) Favourable step	€ 187,210 Equity 2025: € 187,210 ▲ 5% vs 2024 (€ 178,127) Favourable step	▲ 5%
Total debts	€ 136,785 Total debts 2022: € 136,785 First fiscal year in the series	€ 164,229 Total debts 2023: € 164,229 ▲ 20% vs 2022 (€ 136,785) Unfavourable step	€ 127,656 Total debts 2024: € 127,656 ▼ 22% vs 2023 (€ 164,229) Favourable step	€ 131,502 Total debts 2025: € 131,502 ▲ 3% vs 2024 (€ 127,656) Unfavourable step	▲ 3%
Cash	€ 93,587 Cash 2022: € 93,587 First fiscal year in the series	€ 52,079 Cash 2023: € 52,079 ▼ 44% vs 2022 (€ 93,587) Unfavourable step	€ 99,294 Cash 2024: € 99,294 ▲ 91% vs 2023 (€ 52,079) Favourable step	€ 119,866 Cash 2025: € 119,866 ▲ 21% vs 2024 (€ 99,294) Favourable step	▲ 21%
Retained profit	€ 103,101 Retained profit 2022: € 103,101 First fiscal year in the series	€ 143,749 Retained profit 2023: € 143,749 ▲ 39% vs 2022 (€ 103,101) Favourable step	€ 159,527 Retained profit 2024: € 159,527 ▲ 11% vs 2023 (€ 143,749) Favourable step	€ 168,610 Retained profit 2025: € 168,610 ▲ 6% vs 2024 (€ 159,527) Favourable step	▲ 6%
Dividend	€ 5,700 Dividend 2022: € 5,700 First fiscal year in the series	€ 7,600 Dividend 2023: € 7,600 ▲ 33% vs 2022 (€ 5,700) Unchanged	€ 8,100 Dividend 2024: € 8,100 ▲ 7% vs 2023 (€ 7,600) Unchanged	€ 10,900 Dividend 2025: € 10,900 ▲ 35% vs 2024 (€ 8,100) Unchanged	▲ 35%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 28,102 Bank debt 2023: € 28,102 Unchanged (€ 0) Unfavourable step	€ 18,261 Bank debt 2024: € 18,261 ▼ 35% vs 2023 (€ 28,102) Favourable step	€ 7,992 Bank debt 2025: € 7,992 ▼ 56% vs 2024 (€ 18,261) Favourable step	▼ 56%
Balance sheet total	€ 258,486 Balance sheet total 2022: € 258,486 First fiscal year in the series	€ 326,578 Balance sheet total 2023: € 326,578 ▲ 26% vs 2022 (€ 258,486) Unchanged	€ 305,783 Balance sheet total 2024: € 305,783 ▼ 6% vs 2023 (€ 326,578) Unchanged	€ 318,711 Balance sheet total 2025: € 318,711 ▲ 4% vs 2024 (€ 305,783) Unchanged	▲ 4%

Key figures of PHARMACIE DU CHANT DES OISEAUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DU CHANT DES OISEAUX?

What happened at PHARMACIE DU CHANT DES OISEAUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 19,983 (▼ 16% vs 2024). Source: NBB ↗
2023 Isabelle GIBON became a director. NBB
Oct 17, 2000 New establishment in Châtelet. KBO
Oct 2, 2000 Start of the company according to the CBE. KBO

In short

From € 9,757 profit in 2022 to € 19,983 profit in 2025.

Paid € 43,881 in corporate taxes since 2022.

Best year ever: 2023, with € 48,248 profit.

Paid out € 32,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DU CHANT DES OISEAUX? We notify you, reason included.

Follow PHARMACIE DU CHANT DES OISEAUX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle GIBON

PHARMACIE DU CHANT DES OISEAUX

Behind PHARMACIE DU CHANT DES OISEAUX is Isabelle GIBON.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle GIBON

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Gilly 273

6200 Châtelet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0472.886.975

VAT number

BE 0472.886.975

Registered office

Rue de Gilly 273, 6200 Châtelet

Names & denominations

PHARMACIE DU CHANT DES OISEAUX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 October 2000

Peppol

Active · Active since 26 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DU CHANT DES OISEAUX

Financials

What happened to PHARMACIE DU CHANT DES OISEAUX?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions